Coronavirus: Novavax to start human trial for vaccine
Novavax said preliminary immunogenicity and safety results from the trial were expected in July.
A researcher at the University of Pittsburgh works on a COVID-19 vaccine candidate, a fingertip-sized patch with dissolvable microscopic needles, in Pittsburgh, Pennsylvania, U.S.(photo credit: REUTERS)ByREUTERS
